Bayer : Cut in dividend will just slightly reduce Bayer’s elevated leverage
>Bayer plans to slash its dividends by some 95% - Bayer plans to amend its dividend policy to pay out the legally required minimum for three years. The change would result in a dividend of € 0.11 per share for fiscal year 2023. The company said that this decision follows a review of the company’s capital allocation priorities to reduce debt. During Bayer’s Q3 earnings call (8 Nov), Bill Anderson still emphasised the group would stick to its dividend policy to pay out ...Bayer is a life sciences group based in Germany. Co.'s operations are organized along three divisions: Pharmaceuticals (engaged in prescription pharmaceuticals for cardiology and women's healthcare); Consumer Health (engaged in non-prescription products in dermatology, dietary supplement, analgesic, gastrointestinal, allergy, cold and flu, foot care, sun protection and cardiovascular risk prevention categories); and CropScience (engaged in the development of seeds and plant traits; crop protection; and for gardens, the green industry and non-agricultural pest control). Co. also maintains an Animal Health business unit engaged in the development of products for farm and companion animals.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.